Qube Research & Technologies (QRT)’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329M | Sell |
625,980
-76,912
| -11% | -$40.4M | 0.33% | 37 |
|
|
2025
Q1 | $446M | Buy |
702,892
+261,238
| +59% | +$166M | 0.52% | 18 |
|
|
2024
Q4 | $315M | Buy |
441,654
+289,685
| +191% | +$206M | 0.41% | 24 |
|
|
2024
Q3 | $160M | Sell |
151,969
-41,979
| -22% | -$44.1M | 0.24% | 73 |
|
|
2024
Q2 | $204M | Buy |
193,948
+38,100
| +24% | +$40M | 0.32% | 46 |
|
|
2024
Q1 | $150M | Sell |
155,848
-15,516
| -9% | -$14.9M | 0.24% | 90 |
|
|
2023
Q4 | $151M | Buy |
171,364
+165,621
| +2,884% | +$145M | 0.29% | 65 |
|
|
2023
Q3 | $4.73M | Buy |
+5,743
| New | +$4.73M | 0.01% | 755 |
|
|
2023
Q2 | – | Sell |
-4,519
| Closed | -$3.71M | – | 2808 |
|
|
2023
Q1 | $3.71M | Sell |
4,519
-102,160
| -96% | -$83.9M | 0.02% | 697 |
|
|
2022
Q4 | $77M | Buy |
106,679
+98,996
| +1,289% | +$71.4M | 0.41% | 29 |
|
|
2022
Q3 | $5.29M | Sell |
7,683
-75,067
| -91% | -$51.7M | 0.03% | 562 |
|
|
2022
Q2 | $48.9M | Buy |
82,750
+73,120
| +759% | +$43.2M | 0.36% | 48 |
|
|
2022
Q1 | $6.73M | Sell |
9,630
-11,030
| -53% | -$7.7M | 0.06% | 418 |
|
|
2021
Q4 | $13M | Sell |
20,660
-15,985
| -44% | -$10.1M | 0.1% | 244 |
|
|
2021
Q3 | $22.2M | Buy |
+36,645
| New | +$22.2M | 0.28% | 65 |
|
|
2021
Q1 | – | Sell |
-26,622
| Closed | -$12.9M | – | 2324 |
|
|
2020
Q4 | $12.9M | Buy |
26,622
+3,152
| +13% | +$1.52M | 0.18% | 103 |
|
|
2020
Q3 | $13.1M | Buy |
+23,470
| New | +$13.1M | 0.19% | 116 |
|
|
2019
Q3 | – | Sell |
-5,766
| Closed | -$1.81M | – | 418 |
|
|
2019
Q2 | $1.81M | Buy |
+5,766
| New | +$1.81M | 0.43% | 59 |
|
|
2018
Q4 | – | Sell |
-2,756
| Closed | -$1.11M | – | 760 |
|
|
2018
Q3 | $1.11M | Buy |
+2,756
| New | +$1.11M | 0.15% | 112 |
|